Basel, Basel, Switzerland
Business leader with more than 20 years of experience in the life sciences and healthcare industries, known for delivering sustained value through strategic leadership, operational excellence, and cross-functional collaboration. Proven expertise in managing complex projects and building strong relationships across diverse teams and cultures in fast-paced, global environments. Specialized in Engineering, Global Manufacturing & Operations, LEAN Six Sigma, Operational Excellence, Process Re-engineering, Procurement, Project & Risk Management, Strategic Sourcing, and Supply Chain Optimization. A skilled communicator and trusted collaborator, adept at engaging stakeholders at all levels, aligning cross-functional teams, and driving consensus to achieve business-critical outcomes. Recognized for consistently delivering cost reductions, efficiency gains, and long-term strategic value.
• Leading global program management and rollout of a new Line Performance Monitoring System (LPMS) across all Takeda manufacturing sites, enhancing real-time visibility into production performance and driving data-informed decision-making. • Deploying cutting-edge technologies to support Operational Excellence initiatives, enabling Lean and Six Sigma improvements with a strong focus on boosting Overall Equipment Effectiveness (OEE). • Directing the global execution of UPI/DA (Unique Product Identification/Digital Authentication) projects, ensuring seamless integration of serialization technologies into standard equipment in collaboration with external partners and Takeda’s external supply organization.
• Led HSE due diligence for BD&L deals at Novartis under strict confidentiality (NDAs), ensuring compliance with the Novartis Supplier Code, Responsible Procurement Requirements, and global ethical standards such as The Pharmaceutical Supply Chain Initiative (PSCI) and environmental sustainability commitments. • Enabled fast, risk-informed decision-making for Novartis Pharma and Sandoz, supporting the business in seizing strategic commercial opportunities. • Functioned as regional lead for HSE BD&L assessments, aligning onboarding processes with Novartis Due Diligence and Third-Party Risk Management (TPRM) frameworks. • Coordinated and prioritized efforts of a regional team of 10+ HSE professionals, driving consistency and efficiency across assessments.
• Managed strategic partnerships with third-party suppliers and Contract Manufacturing Organizations (CMOs), leading complex, cross-functional projects involving diverse internal stakeholders. • Oversaw technology transfers for a wide range of pharmaceutical products across 25+ third-party manufacturers, ensuring seamless execution of remediation, qualification, and validation activities. • Led global Operational Excellence initiatives within External Supply Operations (ESO), driving LEAN/6σ, continuous improvement, and pFMEA workstreams, as well as cost-reduction programs. • Implemented product security measures to ensure compliance with health authority regulations, including the EU’s Falsified Medicines Directive (FMD).
• Defined product allocation strategies for finished goods manufactured by third parties, leveraging long-term forecasts and capacity analyses to inform make-or-buy decisions and drive third-party footprint reduction. • Streamlined the external vendor network, reducing the number of third-party suppliers from over 600 to fewer than 120 within two years—achieved without supply disruption, significantly lowering costs and risk exposure. • Developed and implemented a comprehensive make-or-buy strategy, optimizing production capacity, enhancing supply chain resilience, and ensuring business continuity—factoring in financial, legal, and funds flow considerations.
• Led interdisciplinary projects and developed tailored solutions within the “Technology and Integration” business unit, serving clients in the pharmaceutical, chemical, and medical device industries—managing budgets, resources, and timelines to ensure successful delivery.
• Managed product and marketing activities for flow meter instrumentation, overseeing lifecycle strategy, market positioning, and customer engagement initiatives.